Work

Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006–2012)

Year: 2021

Type: article

Study design: Observational Study

Source: Journal of Thrombosis and Thrombolysis

DOI: 10.1007/s11239-021-02610-4

Authors: Eric M. Ammann, Elizabeth A. Chrischilles, Ryan M. Carnahan, Bruce Fireman, Candace C. Fuller, Marin L. Schweizer, Crystal Garcia, Madelyn Pimentel, Charles E. Leonard, Meghan A. Baker, Adam Cuker, Enrique C. Leira, Jennifer G. Robinson, Scott K. Winiecki

Institutions: University of Iowa, Johnson & Johnson (United States), Kaiser Permanente Northern California, Harvard University, Harvard Pilgrim Health Care, University of Pennsylvania, University of Iowa Health Care, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Food and Drug Administration

Award: G8054393180

OpenAlex ID: W3216445819

FWCI: 1.562

Cites: 26

Cited by: 8

Related to: 10